{"schema_version":"secwatch.filing_event.v1","accession":"0001576280-26-000004","form_type":"8-K","ticker":"GH","cik":"0001576280","company_name":"Guardant Health, Inc.","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.508769+00:00","generated_at":"2026-05-16T10:51:58.081866+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Guardant Health reports Q4 revenue $280M (+39% YoY); full year revenue $981M (+33%)","bullets":["Q4 oncology tests ~79,000 (+38% YoY); full year ~276,000 (+34%).","Shield screening tests surged to ~38,000 in Q4 (vs 6,400 prior year).","Preliminary free cash flow: -$54M Q4, -$233M full year.","Cash and marketable securities ~$1.3B as of Dec 31, 2025.","Results are preliminary and unaudited; final audited results expected Feb 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001576280-26-000004","json":"https://secwatch.observer/filing/0001576280-26-000004.json","markdown":"https://secwatch.observer/filing/0001576280-26-000004.md","text":"https://secwatch.observer/filing/0001576280-26-000004.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1576280/000157628026000004/0001576280-26-000004-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1576280/000157628026000004/gh-20260111.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:51:58.081866+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}